COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
Rubra Medicaments Ltd
Rubra Medicaments Ltd

Rubra Medicaments Ltd Share Price

  • Sector: Miscellaneous (Small Cap)
  • Volume: 2,015
May 09, 2025
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
24.61
-0.50 (-1.99%)
24.61Low
Today’s Performance
24.61High
6.08Low
52 Week’s Performance
28.88High

bt_logoStock Performance

  • 1 Day-1.99%
  • 1 Week-9.56%
  • 1 Month37.26%
  • 3 Months75.91%
  • 6 Months78.72%
  • 1 Year161.25%
  • 3 Years78.87%
  • 5 Years78.98%

bt_logoPeer Comparison

Price

bt_logoFinancial Analysis

Income Statement (₹ Cr.)

No data for consolidated quarterly .

Balance Sheet (₹ Cr.)

No data for consolidated quarterly .

Cash Flow (₹ Cr.)

No data for consolidated quarterly .

bt_logoRatio Analysis

Return on Equity (%)
No Data For consolidated ROE.
Return on Assets (%)
No Data For consolidated ROE.
Price-to-Earnings (P/E) (X)
No Data For consolidated ROE.
Price to Book (x)
No Data For consolidated ROE.
Return on Capital Employed (%)
No Data For consolidated ROE.
Enterprise Value to EBITDA (X)
No Data For consolidated ROE.
Net Profit Margin (%)
No Data For consolidated ROE.
Gross Profit Margin (%)
No Data For consolidated ROE.
EBITDA Margin (%)
No Data For consolidated ROE.

bt_logoShare Holding Pattern

Summary (As on 31 Mar 2025)

bt_logoDeals

No data for block deals

bt_logoFAQ's

What was Rubra Medicaments Ltd share price previously?
Rubra Medicaments Ltd share price was down by -1.99% from the previous closing price of ₹25.11.
Who are peers of Rubra Medicaments Ltd?
The peers of Rubra Medicaments Ltd are GMR Airports Ltd, International Gemmological Institute (India) Ltd, Embassy Developments Ltd, Rites Ltd, CMS Info Systems Ltd, Thomas Cook (India) Ltd, RattanIndia Enterprises Ltd.
Who is/are the promoter/promoters of Rubra Medicaments Ltd?
The promotor/promotors of Rubra Medicaments Ltd are Abha Kapoor, Sneha Thakur, Gopal Sahu, Harish Surve, Artee Sahu, Saurabh, Pradeep Kumar, Shubham Chaudhary, Shruti Gupta, Bhawna Saunkhiya.
What has been 52-week high of Rubra Medicaments Ltd stocks?
The highest price of Rubra Medicaments Ltd stock is ₹28.88 in the last 52-week.
What is the share price of Rubra Medicaments Ltd (CHECKPOINT) today on BSE?
As on May 09, 2025 Rubra Medicaments Ltd (CHECKPOINT)’s share price on BSE is Rs 24.61
What is the market cap of Rubra Medicaments Ltd (CHECKPOINT)?
The current market capitalisation of Rubra Medicaments Ltd (CHECKPOINT) is 13.74 crores
What is Rubra Medicaments Ltd Share symbol?
The symbol of Rubra Medicaments Ltd is .
What is the PE ratio of Rubra Medicaments Ltd (CHECKPOINT)?
The current PE ratio of Rubra Medicaments Ltd (CHECKPOINT) is -51.24.
What is the PB ratio of Rubra Medicaments Ltd (CHECKPOINT)?
The current PB ratio of Rubra Medicaments Ltd (CHECKPOINT) is 26.70.
Today’s High & Low share prices of Rubra Medicaments Ltd (CHECKPOINT) on BSE?
Today, the share price of Rubra Medicaments Ltd (CHECKPOINT) on BSE touched a high of Rs 24.61 and a low of Rs 24.61
What price did Rubra Medicaments Ltd (CHECKPOINT) shares open on the BSE today?
On BSE, the share price of Rubra Medicaments Ltd (CHECKPOINT) opened at Rs 24.61
What is the 52-week high of Rubra Medicaments Ltd (CHECKPOINT)?
The 52-week high price of Rubra Medicaments Ltd (CHECKPOINT) is Rs 28.88
What is the 52-week low of Rubra Medicaments Ltd (CHECKPOINT)?
The 52-week low price of Rubra Medicaments Ltd (CHECKPOINT) is Rs 6.08

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

OSZAR »